Delisting riskPopularity #4,665
APUS · AMEX · Biotechnology

Apimeds Pharmaceuticals US (APUS)

Developing a bee-venom knee-osteoarthritis therapy and Bitcoin-treasury infrastructure.

$1.74
vs last close−0.11 (−5.70%)

Something off on this page? Send us feedback.

EPSReportedEstimate

May '25Aug '25Nov '25May '26Aug '26
Reported−$0.35−$0.26−$0.14−$22.60−$11.77
Estimate
Surprise

RevenueReportedEstimate

May '25Aug '25Nov '25May '26Aug '26
Reported
Estimate
Surprise

History

Date / PeriodEstimateReportedSurprise
Aug 2026−$11.77
May 2026−$22.60
Nov 2025−$0.14
Aug 2025−$0.26
May 2025

The latest year is open to everyone — the 1 quarter behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Aug 14, 2026−$11.77−3.2%
May 26, 2026−$22.60−5.3%
Nov 12, 2025−$0.14+0.4%
Aug 19, 2025−$0.26+8.6%
May 19, 2025

The latest year is open to everyone — the 1 quarter behind it read with an account.